REM Analytics SA

REM Analytics SA is a Swiss precision microbiome diagnostics company commercializing the proprietary ATGC® platform — a capillary electrophoresis technology delivering strain-level microbial identification at ±3% accuracy, outperforming standard sequencing at a fraction of the cost. Our CE-IVD certified assays address high-value clinical markets: vaginal microbiome (women's health, fertility, menopause) and gut-brain axis diagnostics (Bifidobacterium profiling for mental health and nutrition). Revenue streams combine per-test sales, custom assay development services, and instrument licensing via the Cello 96-capillary system (~CHF 113K/unit + recurring consumables). Products are actively deployed in Switzerland, Brazil, Italy, Spain and Japan.